PMV Pharmaceuticals, Inc.
PMVP· Nasdaq
PMVPPMV Pharmaceuticals, Inc.
Quarterly figures for PMV Pharmaceuticals, Inc., with source filings when available.
30 quarters. Mar 31, 2019 to Jun 30, 2026. mixed units.
PMV Pharmaceuticals, Inc. has filed its 10-Q within 38 to 45 days of period end across its last 8 quarters. The 10-K runs 60 to 65 days.
PMV Pharmaceuticals, Inc. · CIK 1699382 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 14, 2026 · pre-market | Aug 14, 2026 | 45 d | 10-Q | — | — | -$0.34 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 12, 2026 · pre-market |
| May 12, 2026 |
| 42 d |
| 10-Q |
| — |
| — |
| -$0.34 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 6, 2026 · pre-market | Mar 6, 2026 | 65 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · pre-market | Nov 12, 2025 | 43 d | 10-Q | — | — | -$0.40 | |
| Q2 2025 | Jun 30, 2025 | Aug 7, 2025 · pre-market | Aug 7, 2025 | 38 d | 10-Q | — | — | -$0.41 | |
| Q1 2025 | Mar 31, 2025 | May 9, 2025 · pre-market | May 9, 2025 | 39 d | 10-Q | — | — | -$0.34 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 3, 2025 · pre-market | Mar 3, 2025 | 62 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 · pre-market | Nov 7, 2024 | 38 d | 10-Q | — | — | -$0.37 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · pre-market | Aug 8, 2024 | 39 d | 10-Q | — | — | -$0.02 | |
| Q1 2024 | Mar 31, 2024 | May 9, 2024 · pre-market | May 9, 2024 | 39 d | 10-Q | — | — | -$0.30 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 29, 2024 · after-hours | Feb 29, 2024 | 60 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · pre-market | Nov 9, 2023 | 40 d | 10-Q | — | — | -$0.34 | |
| Q2 2023 | Jun 30, 2023 | Aug 9, 2023 · pre-market | Aug 9, 2023 | 40 d | 10-Q | — | — | -$0.38 | |
| Q1 2023 | Mar 31, 2023 | May 10, 2023 · pre-market | May 10, 2023 | 40 d | 10-Q | — | — | -$0.42 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 1, 2023 · pre-market | Mar 1, 2023 | 60 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · pre-market | Nov 8, 2022 | 39 d | 10-Q | — | — | -$0.40 | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · pre-market | Aug 9, 2022 | 40 d | 10-Q | — | — | -$0.38 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · pre-market | May 10, 2022 | 40 d | 10-Q | — | — | -$0.41 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 1, 2022 · pre-market | Mar 1, 2022 | 60 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 · pre-market | Nov 12, 2021 | 43 d | 10-Q | — | — | -$0.33 | |
| Q2 2021 | Jun 30, 2021 | Aug 13, 2021 · pre-market | Aug 13, 2021 | 44 d | 10-Q | — | — | -$0.29 | |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 · pre-market | May 14, 2021 | 44 d | 10-Q | — | — | -$0.26 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | Mar 3, 2021 · after-hours | Mar 3, 2021 | 62 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 · pre-market | Nov 13, 2020 | 44 d | 10-Q | — | — | -$1.46 | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | -$2.62 | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | -$2.38 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | — | — | -$2.03 | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | — | — | — | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | — | |
